You searched for Clinical Outcomes

We found for

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

How do we Measure the “Value” in Value-Based care?

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Public Preferences for Health Gains and Cures: A Discrete Choice Experiment

The Impact of New Medicines in the NHS: 70 Years of Innovation

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

New Methods for Analysing the Distribution of EQ-5D Observations

A New Valuation Method: Directly Eliciting Personal Utility Functions

Why Do Immigrants Report Lower Life Satisfaction?

Age and Utilities: Issues for HTA

Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Important Aspects of Health Not Captured by EQ-5D: Views of the UK General Public

Latest Research & Publications

All Publications

We found for

Filter results by

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

How do we Measure the “Value” in Value-Based care?

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Public Preferences for Health Gains and Cures: A Discrete Choice Experiment

The Impact of New Medicines in the NHS: 70 Years of Innovation

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

New Methods for Analysing the Distribution of EQ-5D Observations

A New Valuation Method: Directly Eliciting Personal Utility Functions

Why Do Immigrants Report Lower Life Satisfaction?

Age and Utilities: Issues for HTA

Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Important Aspects of Health Not Captured by EQ-5D: Views of the UK General Public